Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): A cohort study

The Lancet Psychiatry

Volumn 2, Issue 4, 2015, Pages 314-322

  Degenhardt, Louisa ^a   Bruno, Raimondo ^b   Lintzeris, Nicholas ^c,d   Hall, Wayne ^e,f   Nielsen, Suzanne ^a   Larance, Briony ^a   Cohen, Milton ^g   Campbell, Gabrielle ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER PAIN; CHRONIC PAIN; COHORT ANALYSIS; DISEASE SEVERITY; DRUG ABUSE; DSM-5; DSM-IV; FEMALE; HUMAN; ICD-10; ICD-11; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRESCRIPTION; PROSPECTIVE STUDY; AUSTRALIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACTOR ANALYSIS; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; SOMATOFORM DISORDERS;

ANALGESICS, OPIOID; AUSTRALIA; CHRONIC PAIN; COHORT STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PAIN; PROSPECTIVE STUDIES; SOMATOFORM DISORDERS;

EID: 84926443894     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00005-X     Document Type: Article

References (56)

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: xatic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
2. Beubler E, Jaksch W, Devulder J, et al. The White Paper on opioids and pain: a pan-European challenge: the European White Paper on the use of opioids in chronic pain management. J Pain Palliat Care Pharmacother 2006, 20:79-87. for the Open Mind Initiative.
3. The high price of pain: the economic impact of persistent pain in Australia 2007, Access Economics, MBF Health Insurance, Sydney.
4. Bloodworth D Issues in opioid management. Am J Phys Med Rehabil 2005, 84(suppl):S42-S55.
5. Michna E, Cheng WY, Korves C, et al. Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain management. Pain Med 2014, 15:79-92.
6. Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010, 1. CD006605.
7. Dhalla IA, Mamdani MM, Sivilotti MLA, Kopp A, Qureshi O, Juurlink DN Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009, 181:891-896.
8. Compton WM, Volkow ND Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006, 81:103-107.
9. Roxburgh A, Bruno R, Larance B, Burns L Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011, 195:280-284.
10. Leong M, Murnion B, Haber PS Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009, 39:676-681.
11. Degenhardt L, Black E, Breen C, et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev 2006, 25:403-412.
12. Fischer B, Argento E Prescription opioid related misuse, harms, diversion and interventions in Canada: a review. Pain Physician 2012, 15(suppl):ES191-ES203.
13. Compton WM, Volkow ND Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 2006, 83(suppl 1):S4-S7.
14. The ICD-10 Classification of Mental and Behavioural Disorders-Diagnostic Criteria for Research 1993, WHO, World Health Organization, Geneva.
15. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007, 146:116-127.
16. ICD-11 Beta Draft WHO, (accessed Feb 20, 2014). http://apps.who.int/classifications/icd11/browse/l-m/en.
17. Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, American Psychiatric Association, Washington, DC. Fifth Edition.
18. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) 2000, American Psychiatric Association, American Psychiatric Association, Washington DC. Fourth Edition, Text Revision ed.
19. Baker TB, Breslau N, Covey L, Shiffman S DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. Addiction 2012, 107:263-275.
20. Caetano R There is potential for cultural and social bias in DSM-V. Addiction 2011, 106:885-887.
21. Frances A Issues for DSM-V: the limitations of field trials: a lesson from DSM-IV. Am J Psychiatry 2009, 166:1322.
22. Frances A Opening pandora's box: The 19 worst suggestions for DSM-5. Psychiatric Times (accessed March 9, 2015). http://www.psychiatrictimes.com/display/article/10168/1522341.
23. Frances AJ, Widiger T Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future. Annu Rev Clin Psychol 2012, 8:109-130.
24. Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 2013, 170:834-851.
25. Heit HA, Gourlay DL DSM-V and the definitions: time to get it right. Pain Med 2009, 10:784-786.
26. Meyer RE A commentary on 'Addiction and dependence in DSM-V'. Addiction 2011, 106:873-874.
27. O'Brien C Addiction and dependence in DSM-V. Addiction 2011, 106:866-867.
28. Uchtenhagen A New and remaining problems with DSM-V. Addiction 2011, 106:888-889.
29. Edwards G "The evil genius of the habit": DSM-5 seen in historical context. J Stud Alcohol Drugs 2012, 73:699-701.
30. Martin CS, Steinley DL, Vergés A, Sher KJ The proposed 2/11 symptom algorithm for DSM-5 substance-use disorders is too lenient. Psychol Med 2011, 41:2008-2010.
31. Mewton L, Slade T, McBride O, Grove R, Teesson M An evaluation of the proposed DSM-5 alcohol use disorder criteria using Australian national data. Addiction 2011, 106:941-950.
32. Lintzeris N Commentary on Minozzi et al. (2013): diagnosing opioid dependence in the context of long-term opioid use for chronic pain-counting shades of grey in a black and white world. Addiction 2013, 108:699-700.
33. Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend 2009, 104:43-49.
34. Juurlink DN, Dhalla IA Dependence and addiction during chronic opioid therapy. J Med Toxicol 2012, 8:393-399.
35. Pohl M, Smith L Chronic pain and addiction: challenging co-occurring disorders. J Psychoactive Drugs 2012, 44:119-124.
36. O'Brien CP, Volkow N, Li TK What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry 2006, 163:764-765.
37. Passik SD, Kirsh KL, Webster L Pseudoaddiction revisited: a commentary on clinical and historical considerations. Pain Manag 2011, 1:239-248.
38. Weissman DE, Haddox JD Opioid pseudoaddiction-an iatrogenic syndrome. Pain 1989, 36:363-366.
39. Beynon C Diagnosing the use of illegal drugs by older people-comments on the proposed changes to DSM-V. Addiction 2011, 106:884-885.
40. Campbell G, Mattick R, Bruno R, et al. Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study. BMC Pharmacol Toxicol 2014, 15:17.
41. Kessler RC, Ustün TB The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004, 13:93-121.
42. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004, 291:2581-2590. for the WHO World Mental Health Survey Consortium.
43. Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007, 6:168-176.
44. Seedat S, Scott KM, Angermeyer MC, et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry 2009, 66:785-795.
45. Wang PS, Angermeyer M, Borges G, et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007, 6:177-185.
46. Haro JM, Arbabzadeh-Bouchez S, Brugha TS, et al. Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res 2006, 15:167-180.
47. Morgenstern J, Langenbucher J, Labouvie EW The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria. Addiction 1994, 89:1105-1113.
48. Nelson CB, Rehm J, Ustün TB, Grant B, Chatterji S Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction 1999, 94:843-855.
49. Schreiber JB, Nora A, Stage FK, Barlow EA, King J Reporting Structural Equation Modeling and Confirmatory Factor Analysis Results: A Review. J Educ Res 2006, 99:323-338.
50. Nylund KL, Asparouhov T, Muthén BO Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 2007, 14:535-569.
51. Campbell G, Nielsen S, Bruno R The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2015, 156:231-242.
52. Landis JR, Koch GG The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
53. Boscarino JA, Rukstalis MR, Hoffman SN, et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 2011, 30:185-194.
54. Minozzi S, Amato L, Davoli M Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction 2013, 108:688-698.
55. Chan D So why ask me? Are self-report data really that bad?. Statistical and methodological myths and urban legends: doctrine, verity and fable in the organizational and social sciences? 2009, 309-336. Taylor & Francis, New York. C.E. Lance, R.J. Vandenberg (Eds.).
56. Darke S Self-report among injecting drug users: a review. Drug Alcohol Depend 1998, 51:253-263.